Published in Soc Sci Med on November 14, 2005
Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting. AIDS (2012) 2.63
Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. Am J Clin Nutr (2011) 2.32
The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr (2009) 2.31
Food insecurity among homeless and marginally housed individuals living with HIV/AIDS in San Francisco. AIDS Behav (2009) 1.91
Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications. J Gen Intern Med (2011) 1.37
Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology (2008) 1.30
Secondary prevention of HIV in the United States: past, current, and future perspectives. J Acquir Immune Defic Syndr (2010) 1.29
Discrimination against HIV-infected people and the spread of HIV: some evidence from France. PLoS One (2007) 1.27
A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav (2014) 1.13
Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokodé, Togo. BMC Public Health (2014) 0.92
Sexual risk behavior among people living with HIV and AIDS on antiretroviral therapy at the regional hospital of Sokodé, Togo. BMC Public Health (2014) 0.92
Food insecurity is associated with increased risk of non-adherence to antiretroviral therapy among HIV-infected adults in the Democratic Republic of Congo: a cross-sectional study. PLoS One (2014) 0.91
Sexual addiction: insights from psychoanalysis and functional neuroimaging. Socioaffect Neurosci Psychol (2012) 0.90
Social stability and health: exploring multidimensional social disadvantage. J Urban Health (2012) 0.89
A scoping review and thematic analysis of social and behavioural research among HIV-serodiscordant couples in high-income settings. BMC Public Health (2015) 0.77
Synergistic effects of food insecurity and drug use on medication adherence among people living with HIV infection. J Behav Med (2014) 0.76
Clients' perspectives of the relationship of vulnerability and resilience in the context of HIV infection. Issues Ment Health Nurs (2013) 0.75
Antiretroviral drug diversion links social vulnerability to poor medication adherence in substance abusing populations. AIDS Behav (2015) 0.75
Psychosocial Characteristics Associated with Both Antiretroviral Therapy Adherence and Risk Behaviors in Women Living with HIV. AIDS Behav (2016) 0.75
No variability across centers in adherence and response to HAART in French hospitals: results from the ANRS-EN12-VESPA study. J Acquir Immune Defic Syndr (2009) 0.75
Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis. CMAJ Open (2016) 0.75
A pre-post pilot study of peer nutritional counseling and food insecurity and nutritional outcomes among antiretroviral therapy patients in Honduras. BMC Nutr (2015) 0.75
A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health (1986) 5.38
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet (1985) 3.27
Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS (2000) 2.38
Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet (1984) 2.19
Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol (1995) 2.19
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. J Antimicrob Chemother (2008) 2.17
Natural conception in HIV-negative women with HIV-infected partners. Lancet (1997) 1.98
Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem Biophys Res Commun (1984) 1.94
Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis (2000) 1.86
Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol (1996) 1.84
Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle. Virology (1993) 1.74
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time. Ann Oncol (2011) 1.73
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health (1999) 1.71
Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials (2001) 1.71
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Mandatory prenatal screening for the human immunodeficiency virus: the experience in south-eastern France of a national policy, 1992-1994. Br J Obstet Gynaecol (1998) 1.68
Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS (2001) 1.63
Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor. J Virol (1997) 1.55
The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr (2001) 1.51
Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS (1999) 1.51
Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction (2001) 1.50
Differential mortality: some comparisons between England and Wales, Finland and France, based on inequality measures. Int J Epidemiol (1990) 1.49
[Social inequality in deaths in Great Britain and in France]. Soc Sci Med (1984) 1.43
Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care (2006) 1.41
Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sex Transm Dis (1998) 1.40
Correspondence analysis and logistic modelling: complementary use in the analysis of a health survey among nurses. Stat Med (1988) 1.39
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol (1997) 1.38
Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS (1998) 1.32
The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J Mol Biol (1996) 1.29
Discrimination against HIV-infected people and the spread of HIV: some evidence from France. PLoS One (2007) 1.27
Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Int J Behav Med (2003) 1.24
Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug Alcohol Depend (2006) 1.21
Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients. Clin Exp Immunol (2000) 1.20
Back pain and associated factors in French nurses. Int Arch Occup Environ Health (1994) 1.19
Prevalence of overweight and weight gain in relation to night work in a nurses' cohort. Int J Obes Relat Metab Disord (1996) 1.17
Investigation of a slaughterhouse-related outbreak of Q fever in the French Alps. Eur J Clin Microbiol Infect Dis (2002) 1.16
Factors associated with unprotected anal intercourse among men who have sex with men in Douala, Cameroon. Sex Transm Infect (2009) 1.16
Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment. AIDS Care (2004) 1.13
HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons. AIDS (1994) 1.13
Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. J Gen Virol (1998) 1.12
[Terminal care of patients by the general practitioner and the specialist. Results of a French survey "Attitudes and practices in palliative treatment--2002"]. Presse Med (2003) 1.12
[Epidemiology and social determinants of health inequalities]. Rev Epidemiol Sante Publique (2003) 1.12
Induction of NF-KB during monocyte differentiation by HIV type 1 infection. J Immunol (1991) 1.10
Suicide attempts among people living with HIV in France. AIDS Care (2008) 1.08
Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health (2002) 1.07
Factors associated with efavirenz discontinuation in a large community-based sample of patients. AIDS Care (2004) 1.06
Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs. AIDS Care (2000) 1.06
Disease severity, self-reported experience of workplace discrimination and employment loss during the course of chronic HIV disease: differences according to gender and education. Occup Environ Med (2007) 1.05
The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis. J Gen Virol (1998) 1.02
Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users. Drug Alcohol Depend (2003) 1.02
Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res (2001) 1.02
Survey of the seroprevalence of Bartonella quintana in homeless people. Clin Infect Dis (1996) 1.01
Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. J Virol (1991) 1.00
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability. AIDS Care (2011) 0.97
Urban outbreak of Q fever, Briancon, France, March to June 1996. Euro Surveill (1997) 0.96
French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphine. Addiction (1998) 0.95
Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response. HIV Med (2006) 0.94
Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. J Gen Virol (1991) 0.93
Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR). Virology (1990) 0.93
[Non-compliance in HIV-infected patients, supported by a community association]. Sante Publique (2001) 0.92
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. Drug Alcohol Depend (2000) 0.92
HBV and HIV screening, and hepatitis B immunization programme in the prison of Marseille, France. Int J STD AIDS (1997) 0.92
Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules. AIDS (1999) 0.91
Survey of French prison found that injecting drug use and tattooing occurred. BMJ (1998) 0.90
Prevalence of educational inequalities in obesity between 1970 and 2003 in France. Obes Rev (2009) 0.90
Unsafe sex with casual partners and quality of life among HIV-infected gay men: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA). J Acquir Immune Defic Syndr (2006) 0.89
International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom. Eur J Cancer (2013) 0.89
[Mortality of unskilled workers in different countries of Europe]. Rev Epidemiol Sante Publique (1989) 0.89
Socio-economic conditions, health status and employment among persons living with HIV/AIDS in France in 2001. AIDS Care (2003) 0.89
Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use. AIDS Care (2006) 0.88
Time perspective and quality of life among HIV-infected patients in the context of HAART. AIDS Care (2007) 0.88
HIV screening for pregnant women in south eastern France: evolution 1992-1994-1996. Eur J Obstet Gynecol Reprod Biol (1998) 0.88
The "Swiss Statement": who knows about it? How do they know? What are its effects on people living with HIV/AIDS? AIDS Care (2012) 0.88
Differences in HIV testing, knowledge and attitudes in pregnant women who deliver and those who terminate: Prevagest 1992--France. AIDS Care (1995) 0.88
Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs. Int J STD AIDS (2001) 0.88
Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician. Drug Alcohol Depend (2011) 0.87
Ethical dilemmas in care for HIV infection among French general practitioners. Health Policy (1995) 0.87
Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin. Clin Diagn Lab Immunol (2000) 0.86
Factors related to the prescription of antibiotics for young children with viral pharyngitis by general practitioners and paediatricians in southeastern France. Eur J Clin Microbiol Infect Dis (1999) 0.86
A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells. J Gen Virol (1998) 0.85
[Chief health risks associated with intravenous heroin and cocaine abuse]. Presse Med (2000) 0.85
Isoniazid chemoprophylaxis of latent primary tuberculosis: in five trial centres in France from 1959 to 1969. Int J Epidemiol (1973) 0.85
Stigma, discrimination, and sexual (dis)satisfaction among people living with HIV: results from the "AIDES et toi" survey. AIDS Care (2010) 0.84
HIV testing, knowledge, attitudes, beliefs, and practices among minorities: pregnant women of North-African origin in southeastern France. J Natl Med Assoc (1998) 0.84
Psychotropic drug use and shift work among French nurses (1980-1990). Psychol Med (1995) 0.83
Effects of shift work on sleep among French nurses. A longitudinal study. J Occup Med (1994) 0.83
Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France. HIV Med (2007) 0.83
[A review of socio-behavioural studies on adherence to antiretroviral treatments: beyond biomedical models?]. Rev Epidemiol Sante Publique (2000) 0.83
Lack of legal income is strongly associated with an increased risk of AIDS and death in HIV-infected injecting drug users. AIDS Care (1999) 0.82
Expression of an immunogenic region of HIV by a filamentous bacteriophage vector. Gene (1991) 0.82
Semen alterations in HIV-1 infected men. Hum Reprod (2002) 0.82